AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2017
May 9, 2017
284_dirs_2017-05-09_52cce0c7-fb2b-4e84-8109-e65973d5aab4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2017-05-05
Reporting Person: Karachun Rita A (Sr. VP Fince-Global Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-05-09 | Common Stock | M | 2576.0000 | $0.0000 | Acquired | 17067.9720 | Direct |
| 2017-05-09 | Common Stock | F | 960.0000 | $64.0100 | Disposed | 16107.9720 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-05-05 | Restricted Stock Unit | $ | A | 3283.0000 | Acquired | 2020-05-05 | Common Stock (3283.0000) | Direct |
| 2017-05-05 | Stock Option (right to buy) | $63.9700 | A | 29957.0000 | Acquired | 2027-05-04 | Common Stock (29957.0000) | Direct |
| 2017-05-09 | Restricted Stock Unit | $ | M | 2576.0000 | Disposed | 2017-05-09 | Common Stock (2576.0000) | Direct |
Footnotes
F1: Holdings include shares acquired in dividend reinvestment transactions.
F2: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F3: The option vests and becomes exercisable in three equal instllments on 5/5/2018, 5/5/2019 and 5/5/2020.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8